Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
PIK-294
CHF 0.00
In stock
SYN-1098-M0011 mgCHF 149.00
SYN-1098-M0055 mgCHF 227.00
SYN-1098-M01010 mgCHF 412.00
SYN-1098-M05050 mgCHF 1'263.00
SYN-1098-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | PIK294 |
| Product Type | Chemical |
| Properties | |
| Formula | C28H23N7O2 |
| MW | 489.5 |
| CAS | 900185-02-6 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: PI3K | Kinase Group: Lipid Kinase | Substrate: Lipid Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
| InChi Key | WFSLJOPRIJSOJR-UHFFFAOYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
PIK-294 is a PI3 Kinase inhibitor that is 20- to 60-fold more potent than the parent compound, PIK-293. It is one of the most potent p110δ-selective inhibitors that has been reported, with an IC(50) of 10nM.
Product References
- A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling: Z.A. Knight, et al.; Cell 125, 733 (2006)
Related Products
